Western Family Cavity Control

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the protection against cavities.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Adults and children aged 2 years and older are advised to brush their teeth thoroughly, preferably after each meal, or at least twice daily, or as directed by a dentist. It is important to ensure that the product is not swallowed during the brushing process.

For children under 6 years of age, a pea-sized amount of the product should be used to minimize the risk of swallowing. Caregivers should supervise the brushing process until proper oral hygiene habits are established.

For children under 2 years of age, it is recommended to consult a dentist or physician for appropriate guidance on the use of this product.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence.

Warnings and Precautions

As with all fluoride toothpastes, it is imperative to keep this product out of the reach of children under 6 years of age. In the event of accidental ingestion of an amount greater than that typically used for brushing, it is crucial to seek professional medical assistance or contact a Poison Control Center immediately.

No additional general precautions, laboratory tests, or emergency instructions are provided in the insert. Healthcare professionals are advised to remain vigilant regarding the safe use of this product and to educate patients on the importance of adhering to the recommended guidelines for fluoride toothpaste usage.

Side Effects

Patients should be aware of the potential risks associated with the use of fluoride toothpaste. It is important to keep the product out of reach of children under 6 years of age to prevent accidental ingestion. In the event that a child accidentally swallows more than the amount typically used for brushing, it is crucial to seek professional help or contact a Poison Control Center immediately. This precaution is essential to ensure the safety and well-being of young children who may be more susceptible to the adverse effects of fluoride.

Drug Interactions

No drug interactions have been identified for the product, indicating that it does not have any known pharmacodynamic or pharmacokinetic interactions with other medications. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Western Family Cavity Control (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be supervised during the use of fluoride toothpaste to minimize the risk of swallowing. For children under 6 years of age, it is recommended to use a pea-sized amount of toothpaste and to supervise brushing until proper habits are established. The use of fluoride toothpaste is not advised for children under 2 years of age without consulting a dentist or physician.

For adults and children aged 2 years and older, it is advised to brush teeth thoroughly, preferably after each meal or at least twice a day, and to avoid swallowing the toothpaste. Caregivers should ensure that fluoride toothpaste is kept out of reach of children under 6 years of age. In the event of accidental ingestion of more than the amount used for brushing, professional help or contact with a Poison Control Center should be sought immediately.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment.

Lactation

There is no specific information regarding nursing mothers or lactation considerations provided in the drug insert for Western Family Cavity Control - sodium fluoride paste, dentifrice. Therefore, the effects on breastfed infants and the excretion of the drug in breast milk are not established. Healthcare professionals should consider this lack of data when advising lactating mothers on the use of this product.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is imperative that healthcare professionals take immediate action. If a patient accidentally ingests more than the recommended amount used for brushing, it is crucial to seek professional assistance without delay.

Healthcare providers should advise the patient or caregiver to contact a Poison Control Center immediately for guidance on the appropriate steps to take. Prompt intervention is essential to mitigate potential adverse effects associated with overdosage.

Monitoring for symptoms related to overdosage may be necessary, although specific symptoms are not detailed in the provided information. Therefore, vigilance in assessing the patient's condition and readiness to implement management procedures is advised.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of the reach of children to prevent accidental ingestion or misuse. It is important for patients to understand the potential risks associated with improper access to the medication by young individuals. Emphasizing the need for secure storage can help ensure the safety of children in the household.

Storage and Handling

The product is supplied in a configuration that ensures optimal handling and storage. It should be stored at room temperature to maintain its efficacy. It is essential to keep the product out of reach of children under 6 years of age to prevent accidental ingestion. Once opened, the product must be discarded to ensure safety and effectiveness.

Additional Clinical Information

The route of administration for the product is dental. Clinicians should advise patients to keep the product out of reach of children under 6 years of age. In the event of accidental ingestion of more than the amount used for brushing, patients should seek professional help or contact a Poison Control Center immediately. To minimize the risk of swallowing, it is recommended to use a pea-sized amount and supervise brushing until good habits are established. For children under 2 years of age, consultation with a dentist or physician is advised.

Drug Information (PDF)

This file contains official product information for Western Family Cavity Control, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)